Covalon Technologies Ltd. (CVALF) Financials
CVALF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 23.9 million | 3.7 million |
| Dec. 31, 2025 | 23.9 million | 4.7 million |
| Sept. 30, 2025 | 25.9 million | 3.9 million |
| June 30, 2025 | 25.9 million | 4.1 million |
CVALF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -952107 | ? |
| Dec. 31, 2025 | 3.7 million | ? |
| Sept. 30, 2025 | -402829 | 45700 |
| June 30, 2025 | 1.3 million | 39965 |
CVALF Net Income
No data available :(
CVALF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 11.9 million | - | 1.0 million |
| Dec. 31, 2025 | 13.0 million | 1.1 million | 1.1 million |
| Sept. 30, 2025 | 12.5 million | 1.2 million | 1.6 million |
| June 30, 2025 | 13.3 million | 538127 | 939042 |
CVALF Shares Outstanding
CVALF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 124211 | - | 2.9 million | - |
| Dec. 31, 2025 | 475582 | 193174 | 2.6 million | - |
| Sept. 30, 2025 | 58783 | 226089 | 2.4 million | 841242 |
| June 30, 2025 | 324938 | 228821 | 2.2 million | 823933 |
CVALF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 6.3 million | 2.6 million |
| Dec. 31, 2025 | 5.0 million | 2.2 million |
| Sept. 30, 2025 | 6.2 million | 3.0 million |
| June 30, 2025 | 6.2 million | 3.3 million |
CVALF
Price: $1.54
52 week price:
Dividend Yield: 6.99%
Earnings Per Share: 0.05 USD
P/E Ratio: 27.60
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 42.0 million